Recently, WuXi AppTec and Huawei have signed a strategic cloud cooperation agreement in precision medical in Shenzhen. The two sides will combine rich experience and technical abilities in genomics and precision medical of WuXi NextcoDE，which is the subsidiary of WuXi AppTec , with industry-leading cloud infrastructure and service capabilities of Huawei, to advance precision medical cloud platform.

It’s reported that WuXi AppTec and Huawei will comply with the relevant provisions of the State Food and Drug Administration (CFDA). Through cooperation with third-party internet security cloud life science suppliers, they will jointly develop data standards and exchange frameworks for China Precision Medical Plan .

Doctor Li Ge, Chairman & CEO of WuXi AppTec said in a statement that the partnership aimed to promote the genome medical to serve patients with an unprecedented scale. And they will combine leading-edge technologies and capabilities of their respective areas to jointly promote the early realization of this goal.

Hannes Smarason, chief operating officer of WuXi NextcoDE, said, “this cooperation will realize win-win not only in our two companies, but also all patients who will benefit from the plan of precision medical. We are very pleased to develop this cooperation with Huawei, and use the related leading technology to serve everyone in China. We are trying to promote the standards of establishment of global genomic medicine , and China will be the core of this strategy.”